FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to oncology, and can be used for treatment of subject's bone tumour. For this purpose bone tumour in subject is, at least, partially ablated. Area, adjacent to the bone section, where tumour was, at least, partially ablated, is brought into contact with gel, containing taurolidine, taurultam, their mixture or their solution, which is in equilibrium. Also claimed is prevention of development of bone tumour recurrence in subject.
EFFECT: group of inventions ensures treatment and prevention of osteosarcoma in subject due to application of gel of suggested medications.
40 cl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
ADHESIVE ANTITUMORAL COMPOSITIONS | 2004 |
|
RU2343924C2 |
BONE MATERIAL AND COLLAGEN COMPOSITION FOR RESTORING INJURED ARTICULATIONS | 2001 |
|
RU2292858C2 |
ANTIMICROBIAL COMPOSITIONS OF WIDE SPECTRUM OF ACTION BASED ON TAUROLIDINE AND PROTAMINE COMBININATIONS AND MEDICAL DEVICES CONTAINING SUCH COMPOSITIONS | 2012 |
|
RU2628539C2 |
METHOD FOR THERMAL ABLATION OF BONE TUMOUR | 2013 |
|
RU2527363C1 |
APPLICATION OF A NEW TYROSINKINASE INHIBITOR, ANLOTINIBA, IN OSTEOSARCOMA AND CHONDROSARCOMA | 2019 |
|
RU2787235C2 |
METHOD FOR INTRAOPERATIVE HYPERTHERMIC EXPOSURE ON BONE TISSUE | 2018 |
|
RU2695305C1 |
CYTARABINE CONJUGATES FOR TREATING CANCER | 2016 |
|
RU2708672C1 |
METHOD OF OBTAINING CIS-DIAMMONIUM-DICHLORODIHYDROXOPLATINUM (IV) AND ITS APPLICATION | 2004 |
|
RU2345086C2 |
PHORBOL ESTER COMPOSITIONS AND METHODS OF USING THEM FOR TREATING OR REDUCING DURATION OF CYTOPENIA | 2015 |
|
RU2730998C2 |
RESORBABLE EXTRACELLULAR MATRIX CONTAINING COLLAGEN I AND COLLAGEN II FOR RESTRUCTURING CARTILAGE | 2002 |
|
RU2323011C2 |
Authors
Dates
2012-12-10—Published
2007-09-06—Filed